FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefoxitin for Injection, USP
Status: Currently in Shortage
»Date first posted: 05/03/2019
»Therapeutic Categories: Anti-Infective

Expand all

Apotex Corp. (Reverified 02/18/2020)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (25 vials) (NDC 60505-0759-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
2 g (25 vials) (NDC 60505-0760-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
10 g (10 vials) (NDC 60505-0761-04) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug

B. Braun Medical Inc. (Reverified 01/29/2020)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cefoxitin Injection 2 gram/50 mL in DUPLEX Catalog 3125-11 (NDC NDC 00264-3125-11) Product on allocation to contracted customers Other
Cefoxitin Injection 1 gram/50 mL in DUPLEX Catalog 3123-11 (NDC 0264-3123-11) Product on allocation to contracted customers Other

Fresenius Kabi USA, LLC (Revised 02/20/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g per vial; SDV; (NDC 63323-341-25) Available Check wholesalers for inventory Manufacturing delays
2 grams per vial; SDV; (NDC 63323-342-25) Backordered. Next release June 2020. Check wholesalers for inventory Manufacturing delays

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 02/07/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1g vial (NDC 0143-9878-25) This presentation is on backorder. Availability expected middle of 2020. Product will be made available as it is released. Other
2g vial (NDC 0143-9877-25) This presentation is on backorder. Availability expected middle of 2020. Product will be made available as it is released. Other
10g vial (NDC 0143-9876-10) This presentation is on backorder. Availability expected middle of 2020. Product will be made available as it is released. Other

Sagent Pharmaceuticals (Reverified 02/20/2020)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 g, package of 10 vials (NDC 25021-111-99) Backorder. Estimated availability Apr-2020 Demand increase for the drug
1 g, package of 10 vials (NDC 25021-109-10) Available Manufacturing delay
2 g, package of 10 vials (NDC 25021-110-20) Backorder. Estimated availability Apr-2020 Demand increase for the drug

WG Critical Care (Revised 01/29/2020)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (NDC 44567-245-25) Available Please check wholesalers for available inventory. Demand increase for the drug
2 g (NDC 44567-246-25) Available Please check wholesalers for available inventory. Demand increase for the drug
10 g (NDC 44567-247-10) Available Please check wholesalers for available inventory. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English